Socioeconomic Disparities and Mediators for Recurrent Atherosclerotic Cardiovascular Disease Events After a First Myocardial Infarction

Author:

Ohm Joel123ORCID,Kuja-Halkola Ralf4ORCID,Warnqvist Anna5ORCID,Häbel Henrike5ORCID,Skoglund Per H.36,Sundström Johan7ORCID,Hambraeus Kristina8,Jernberg Tomas9,Svensson Per1011ORCID

Affiliation:

1. Department of Emergency Medicine Solna (J.O.), Karolinska University Hospital, Stockholm, Sweden.

2. Coagulation Unit, Department of Hematology (J.O.), Karolinska University Hospital, Stockholm, Sweden.

3. Department of Medicine Solna (J.O., P.H.S.), Karolinska Institutet, Stockholm, Sweden.

4. Department of Medical Epidemiology and Biostatistics (R.K.-H.), Karolinska Institutet, Stockholm, Sweden.

5. Institute of Environmental Medicine, Division of Biostatistics (A.W., H.H.), Karolinska Institutet, Stockholm, Sweden.

6. Center for Palliative Care, Stiftelsen Stockholms Sjukhem, Stockholm, Sweden (P.H.S.).

7. Department of Medical Sciences, Uppsala University, Sweden (J.S.).

8. Department of Cardiology, Falu Hospital, Falun, Sweden (K.H.).

9. Department of Clinical Sciences, Danderyd University Hospital (T.J.), Karolinska Institutet, Stockholm, Sweden.

10. Department of Clinical Science and Education, Södersjukhuset (P.S.), Karolinska Institutet, Stockholm, Sweden.

11. Department of Cardiology, Södersjukhuset, Stockholm, Sweden (P.S.).

Abstract

BACKGROUND: Low socioeconomic status is associated with worse secondary prevention use and prognosis after myocardial infarction (MI). Actions for health equity improvements warrant identification of risk mediators. Therefore, we assessed mediators of the association between socioeconomic status and first recurrent atherosclerotic cardiovascular disease event (rASCVD) after MI. METHODS: In this cohort study on 1-year survivors of first-ever MI with Swedish universal health coverage ages 18 to 76 years, individual-level data from SWEDEHEART (Swedish Web System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies) and linked national registries was collected from 2006 through 2020. Exposure was socioeconomic status by disposable income quintile (principal proxy), educational level, and marital status. The primary outcome was rASCVD and secondary outcomes were cardiovascular and all-cause mortality. We initially assessed the incremental attenuation of hazard ratios with 95% CIs in sequential multivariable models adding groups of potential mediators (ie, previous risk factors, acute presentation and infarct severity, initial therapies, and secondary prevention). Thereafter, the proportion of excess rASCVD associated with a low income mediated through nonparticipation in cardiac rehabilitation, suboptimal statin management, a cardiometabolic risk profile, persistent smoking, and blood pressure above target after MI were calculated using causal mediation analysis. RESULTS: Among 68 775 participants (73.8% men), 7064 rASCVD occurred during a mean 5.7-year follow-up. Income, adjusted for age, sex, and calendar year, was associated with rASCVD (hazard ratio, 1.63 [95% CI, 1.51–1.76] in the lowest versus highest income quintile). Risk attenuated most by adjustment for previous risk factors and by adding secondary prevention variables for a final model (hazard ratio, 1.38 [95% CI, 1.26–1.51]) in the lowest versus highest income quintile. The proportions of the excess 15-year rASCVD risk in the lowest income quintile mediated through nonparticipation in cardiac rehabilitation, cardiometabolic risk profile, persistent smoking, and poor blood pressure control were 3.3% (95% CI 2.1–4.8), 3.9% (95% CI, 2.9–5.5), 15.2% (95% 9.1–25.7), and 1.0% (95% CI 0.6–1.5), respectively. Risk mediation through optimal statin management was negligible. CONCLUSIONS: Nonparticipation in cardiac rehabilitation, a cardiometabolic risk profile, and persistent smoking mediate income-dependent prognosis after MI. In the absence of randomized trials, this causal inference approach may guide decisions to improve health equity.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. What Is Mediation Analysis?;JACC: Advances;2024-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3